Home » Why does Taiwan’s BNT purchase of the vaccine at the end of the drama involve sensitive cross-strait relations-BBC News

Why does Taiwan’s BNT purchase of the vaccine at the end of the drama involve sensitive cross-strait relations-BBC News

by admin

Image source,Taiwan president office

Image with text,

TSMC Chairman Liu Deyin (first from left) and Hon Hai Director Guo Taiming (second from left) were invited to meet with Tsai Ing-wen (first from right), which was regarded as an important turning point in the procurement of BNT vaccines.

The purchase of the BioNTech vaccine (called BNT in Taiwan, Fubitai in Hong Kong and Macau, and Pfizer Vaccine in Europe and America), which has been boiling for many days in Taiwan, has made a breakthrough this week.

Taiwan’s two major electronics manufacturers, TSMC and Hon Hai, announced on Monday (July 12) that they had signed a four-party contract with Shanghai Fosun and Yuli Pharmaceutical, confirming the purchase of 10 million doses of BNT vaccine, each of which will be funded by the two companies to purchase 5 million doses for donation The Taiwan government is expected to arrive in Taiwan at the end of September at the earliest. Shanghai Fosun Pharmaceutical Group also issued an announcement on the evening of the 11th, announcing the transaction.

A vaccine procurement that seems urgent and not difficult to the outside world takes a long time. According to external analysis, since the government started to purchase BNT vaccines in Taiwan last year, and finally confirmed the order by the two companies, the process can be described as a twists and turns, involving cross-strait governments, the intervention of the United States and Japan, and even the attitude of the vaccine-producing country Germany. This vaccine purchase, which was originally a commercial nature, was given a strong political color during the sensitive period of cross-strait relations.

Behind the rare procurement model

It is up to the company to purchase such a large number of vaccines throughout the process, and the government is responsible for reviewing and deciding whether to approve it. This vaccine procurement model is very rare in the current global new crown epidemic prevention operations.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy